companydata.dkDraupnir Bio ApS: Financial statements 2018
CVR: 38546880
Draupnir Bio ApS (CVR 38546880) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -1,779,479 and a net result of DKK -2,117,554. Equity amounted to DKK -1,788,946. The company had 1 employee in the financial year.
- Gross Profit
- -1,779,479 kr.
- Profit/Loss
- -2,117,554 kr.
- Equity
- -1,788,946 kr.
- Total Assets
- 4,582,267 kr.
- Employees
- 1
Keep an eye on Draupnir Bio ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
As of October 26, 2018, Emmanuelle Coutanceau has joined the board of directors of Draupnir Bio ApS.
As of October 26, 2018, Peter Hans Andreas Seeberger has joined the board of directors of Draupnir Bio ApS.
As of October 26, 2018, Camilla Gustafsen has left the board of directors of Draupnir Bio ApS.
As of October 26, 2018, Simon Glerup Pedersen has left the board of directors of Draupnir Bio ApS.
As of October 26, 2018, Peder Søndergaard Madsen has left the board of directors of Draupnir Bio ApS.
Draupnir Bio ApS has published its interim report for the period April 4, 2017 – December 31, 2017.
About Draupnir Bio ApS
Draupnir Bio ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Andrew Thomas Hotchkiss. The company's owners include Novo Holdings A/S, Coöperatieve Gilde Healthcare IV U.A. and Danmarks Eksport- og Investeringsfond. Equity amounted to DKK 15,256,000.